Is KLRA or KLRS more undervalued in 2026?

CirclFi compares Kailera Therapeutics, Inc. (KLRA) and Kalaris Therapeutics, Inc. (KLRS) using 13 institutional-grade valuation models. KLRA has a Quality of Company score of 1.7/10 while KLRS scores 4.1/10.

Which is a better buy — KLRA or KLRS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do KLRA and KLRS valuations compare?

KLRA at $22.94 and KLRS at $5.18 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

KLRA vs KLRS Valuation Comparison 2026 — Intrinsic Value Analysis

KLRA

Biotechnology

Kailera Therapeutics, Inc.

Quality

1.7

out of 10

Value Trap

—

Price

$22.94

Last close

Models

5/13

Active

KLRS

Biotechnology

Kalaris Therapeutics, Inc.

Quality

4.1

out of 10

Value Trap

LOW

Price

$5.18

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	KLRA Fair Value	KLRA Upside	KLRS Fair Value	KLRS Upside
Bayesian DCF	Intrinsic	$6.77	-70.5%	$0.45	-91.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.48	-84.8%	$0.16	-97.0%
Dynamic NAV	Asset-Based	—	—	$1.17	-77.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for KLRA vs KLRS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KLRA vs KLRS — Which Stock Is More Undervalued?

KLRS scores higher with a 4.1/10 quality rating vs KLRA's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kailera Therapeutics, Inc. (KLRA) and Kalaris Therapeutics, Inc. (KLRS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KLRA currently trades at $22.94 with a QOC of 1.7/10, while KLRS trades at $5.18 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).